Back to Journals » Drug Design, Development and Therapy » Volume 14

The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution

Total article views   HTML views PDF downloads Totals
5,426 Dovepress* 5,176+ 871 6,047
PubMed Central* 250 122 372
Totals 5,426 993 6,419
*Since 25 September 2020

View citations on PubMed Central and Google Scholar